Fundraising Fox

Research Corporation Technologies β€” Full Portfolio

29 tracked investments Β· listed companies and verified rows first

Esperancepharmaesperancepharma.comJun 2019βœ“ verified

Esperance develops targeted oncology therapeutics designed to selectively kill cancer cells, including chemotherapy-resistant cells, via a proprietary Cationic Lytic Peptide (CLYP) platform, membrane-disrupting peptides, and antibody drug conjugates.

BiotechHealthtechHouston, US

Hector Alila(Executive Officer, Director)Ross Barrett(Director)Peter Hoang(Director)Sonia Deggs(Executive Officer)Carola Leuschner(Executive Officer)

BoardJoseph Lovett(Director)

Co-investorsLouisiana Funds

Pheontxpheontx.cominβœ“ verified

Pheon Therapeutics develops targeted oncology treatments, focusing on antibody-drug conjugates (ADCs) for cancer therapy.

BiotechHealthtechMedical Devices

Co-investorsAtlas VentureBiotechnology Value FundForbionLightspeed Venture PartnersTCG Crossover

Alchemia
Alerion Biomedical
APT Pharmaceuticals
Aragen Bioscience, LLC

BiotechMorgan Hill, US

William R. Srigley(Executive Officer, Director)Christian C. Simonsen(Executive Officer)

BoardManmahesh Kantipudi(Director)J.B. Gupta(Director)

Arana Therapeutics, Ltd
BioCisionDec 2014

Advanced ManufacturingSan Rafael, US

Rolf O. Ehrhardt(Executive Officer, Director)Ron DiNocco(Executive Officer)Brian Schryver(Director)

BoardPaul E. Nowak(Director)Hugh Douglas(Director)Blair W. Stewart(Director)

Bionomics
BioVentures Australia
Catalyst Biosciences Inc.Jan 2015

BiotechSouth San Fransicso, US

Nassim Usman(Executive Officer, Director)

BoardAugustine Lawlor(Director)Ralph Christoffersen(Director)inJeff Himawan(Director)Michael Powell(Director)Asish Xavier(Director)

Co-investorsLightstone Ventures

Coronis Medical Ventures, LLC
CryoFluor Therapeutics LLC
Cylene Pharmaceuticals
Fullerene International Corporation
Kerberos Proximal Solutions Inc.
Leto Medical LLC
Npphotonicsnpphotonics.comin

NP Photonics designs and manufactures fiber-based photonics products, including narrow-linewidth single-frequency fiber lasers, high-power fiber lasers, multi-channel laser systems, fiber amplifiers, injection seeders, mid-infrared fiber sources, and ASE sources.

Advanced ManufacturingDeep TechDefense TechHardwareNew MaterialsTucson, US

Co-investorsShepherd Ventures

OncoGenex Technologies
ParinGenix Inc.
S2 Genomics

BiotechLivermore, US

Stevan Jovanovich(Executive Officer, Director)Peter Wagner(Executive Officer, Director)

BoardMichael Wiley(Director)Shannon Hall(Director)Michael Finney(Director)

s2.devs2.devin𝕏Jan 2024 Β· $16M

S2.dev builds infrastructure services and tools for developers.

Cloud ComputingData & InfrastructureDeveloper ToolsEnterprise SoftwareSan Francisco, US

Shikhar Bhushan(Co-founder and CEO)inStephen Balogh(Co-founder and CTO)inDwarak Govind Parthiban(Co-founder)inMehul ArorainCristian Caciucin

Co-investorsOrange CollectiveTranspose Platform ManagementY Combinator

seqWellseqwell.comin𝕏

seqWell develops reagents and technologies for next-generation sequencing library preparation, serving academic and institutional research clients.

BiotechDeep TechBeverly, US

Thomas Grant(Executive Officer)inDaniel Calvo(Executive Officer, Director)JoeJackJoseph Mellor(Executive Officer, Director)Joseph Mellor, Ph.D.(Executive Officer, Director)

Sertoli Technologies Inc.
Spirogen Ltd.
Therapeutic Human Polyclonals, Inc.
Valeo Medical Inc.
Varix Medical Corp.
VasoNova, Inc.

Co-investorsCalifornia Technology Ventures

Rows marked β€œSEC filing” are inferred from directors named on the company's SEC Form D β€” public regulatory data, not a portfolio list published by the firm.